We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
MENQUADFI Sanofi-Aventis Australia Pty Ltd
Product name
MENQUADFI
Sponsor
Accepted date
Apr-2025
Active ingredients
Meningococcal polysaccharide Group Y, Meningococcal polysaccharide group A, Meningococcal polysaccharide group C, Meningococcal polysaccharide group W135
Proposed indication
MenQuadfi is a vaccine, for people from 6 weeks of age, that immunises against serious meningococcal disease (which is caused by the bacteria Neisseria meningitidis).
Application type
C (new indication)
Publication date
Apr-2025